https://www.pathos.com/platform-old 1.0 monthly 2026-01-09 https://www.pathos.com/contact-us 1.0 monthly 2026-01-09 https://www.pathos.com/home-old 1.0 monthly 2026-01-09 https://www.pathos.com/privacy-policy 1.0 monthly 2026-01-08 https://www.pathos.com/patients 1.0 monthly 2026-01-09 https://www.pathos.com/partners 1.0 monthly 2026-01-09 https://www.pathos.com/news/collaboration 1.0 monthly 2026-01-09 https://www.pathos.com/partner_with_us 1.0 monthly 2026-01-08 https://www.pathos.com/news/funding 1.0 monthly 2026-01-09 https://www.pathos.com/news 1.0 monthly 2026-01-09 https://www.pathos.com/careers 1.0 monthly 2026-01-09 https://www.pathos.com/pipeline 1.0 monthly 2026-01-09 https://www.pathos.com/news/leadership 1.0 monthly 2026-01-09 https://www.pathos.com/about-us 1.0 monthly 2026-03-24 https://www.pathos.com/platform 1.0 monthly 2026-01-09 https://www.pathos.com/news/clinical_updates 1.0 monthly 2026-01-09 https://www.pathos.com 1.0 monthly 2026-01-27 https://www.pathos.com/re-engineering-drug-development-for-precision-medicine 0.8 monthly 2026-01-08 https://www.pathos.com/pathos-launches-precision-oncology-pipeline-with-license-of-first-phase-i-program-a-cbp-p300-inhibitor 0.8 monthly 2026-01-08 https://www.pathos.com/pathos-ai-completes-acquisition-of-rain-oncology 0.8 monthly 2026-01-08 https://www.pathos.com/pathos-expands-pipeline-with-worldwide-license-of-phase-2-ready-program-a-brain-penetrant-prmt5-inhibitor 0.8 monthly 2026-01-08 https://www.pathos.com/pathos-ai-closes-62m-oversubscribed-series-c-round-of-financing-to-accelerate-its-platform-approach-to-drug-development 0.8 monthly 2026-01-08 https://www.pathos.com/pathos-ai-doses-first-patient-in-phase-1b-2a-clinical-trial-of-pocenbrodib-a-cbp-p300-inhibitor 0.8 monthly 2026-01-08 https://www.pathos.com/pathos-signs-strategic-agreements-with-astrazeneca-and-tempus-to-develop-the-largest-multimodal-foundation-model-in-oncology 0.8 monthly 2026-01-08 https://www.pathos.com/pathos-ai-appoints-iker-huerga-as-chief-executive-officer-to-lead-the-next-era-of-ai-enabled-drug-development 0.8 monthly 2026-01-08 https://www.pathos.com/pathos-ai-secures-365-million-in-series-d-financing-to-advance-oncology-drug-development-through-ai 0.8 monthly 2026-01-08